AP Biosciences, Inc. (TPEX:6945)
Taiwan · Delayed Price · Currency is TWD 148.50
+8.50 (6.07%)
Sep 30, 2026, 1:30 PM CST
AP Biosciences Market Cap
AP Biosciences has a market cap or net worth of 13.65 billion as of September 29, 2026. Its market cap has increased by 38.90% in one year.
Market Cap
13.65B
Enterprise Value
11.51B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
148.50
ChartMarket Cap Chart
Since July 14, 2023, AP Biosciences's market cap has increased from 5.10B to 13.65B, an increase of 167.96%. That is a compound annual growth rate of 35.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 13.65B | -10.87% |
| Dec 31, 2025 | 15.32B | 262.77% |
| Dec 31, 2024 | 4.22B | 39.97% |
| Dec 29, 2023 | 3.02B | -40.79% |
| Jul 14, 2023 | 5.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medigen Vaccine Biologics | 19.66B |
| TaiMed Biologics | 16.97B |
| Gongwin Biopharm Holdings | 16.59B |
| ACRO Biomedical | 16.34B |
| Ever Supreme Bio Technology | 16.07B |
| Steminent Biotherapeutics | 15.87B |
| EirGenix | 15.35B |
| Lumosa Therapeutics | 13.48B |